Peripheral Arterial Disease and Chronic Kidney Disease

1. O’Hare AM, Glidden DV, Fox CS, Hsu CY. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2004; 109:320.10.1161/01.CIR.0000114519.75433.DDSearch in Google Scholar

2. O’Hare AM, Vittinghoff E, Hsia J, Shlipak MG. Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS). J Am Soc Nephrol 2004; 15:1046.10.1097/01.ASN.0000119574.27772.FDSearch in Google Scholar

3. Wattanakit K, Folsom AR, Selvin E, et al. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol 2007; 18:629.10.1681/ASN.2005111204Open DOISearch in Google Scholar

4. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16(2):489–495.10.1681/ASN.2004030203Search in Google Scholar

5. Eggers PW, Godhes D, Pugh J. Nontraumatic extremity amputations in the Medicare end-stage renal disease population. Kidney Int. 1999;56 (4):1524-3310.1046/j.1523-1755.1999.00668.xOpen DOISearch in Google Scholar

6. Menon V. Gul A, Sarnak MJ. Cardiovascular risk factors in chronic kidney disease. Kidney Int. 2005;68(4):1413-8.10.1111/j.1523-1755.2005.00551.xSearch in Google Scholar

7. Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, Fox CS, Gansevoort RT, Heerspink HJL, Jardine M, Kasiske B, Köttgen A, Kretzler M, Levey AS, Luyckx VA, Mehta R, Moe O, Obrador G, Pannu N, Parikh CR, Perkovic V, Pollock C, Stenvinkel P, Tuttle KR, Wheeler DC, Eckardt KU; ISN Global Kidney Health Summit participants. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017 Apr 20. pii: S0140-6736(17)30788-2. doi: 10.1016/S0140-6736(17)30788-2.10.1016/S0140-6736(17)30788-2Open DOISearch in Google Scholar

8. Authors/Task Force Members:, Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WM, Vlachopoulos C, Wood DA, Zamorano JL. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016;253:281-344.10.1016/j.atherosclerosis.2016.08.01827594540Search in Google Scholar

9. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007 Jul 3;116(1):85-97.10.1161/CIRCULATIONAHA.106.67834217606856Search in Google Scholar

10. Gross P, Six I, Kamel S, Massy ZA. Vascular toxicity of phosphate in chronic kidney disease: beyond vascular calcification. Circ J. 2014;78(10):2339-46.10.1253/circj.CJ-14-0735Search in Google Scholar

11. Bosevski M, Borozanov V, Tosev S, Georgievska-Ismail Lj. Is assessment of eripheral endothelial dysfunction useful tool for risk stratification of type 2 diabetic patients with manifested coronary artery disease? Int J Cardiol. 2009 Jan 9;131(2):290-2.10.1016/j.ijcard.2007.08.01117964674Search in Google Scholar

12. Smink PA, Lambers Heerspink HJ, Gansevoort RT, de Jong PE, Hillege HL, Bakker SJ, de Zeeuw D. Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study. Am J Kidney Dis. 2012 Nov;60(5):804-1110.1053/j.ajkd.2012.06.01722835901Open DOISearch in Google Scholar

13. Chang A, Kramer H. Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney diseaseand cardiovascular disease risk prediction. Nephron Clin Pract. 2011;119(2):c171-7;10.1159/00032566921811078Search in Google Scholar

14. Dzekova Vidimliski P, Ivanovski N, Bosevski M, Busletic I, Sikole A. Association betwwn Hepatitis C and Carotid IMT in renal transplant recipient. Int journal of artificial organs 32(7):443-443Search in Google Scholar

15. Selim G, Stojceva-Taneva O, Zafirovska K, Sikole A, Gelev S, Dzekova P, Stefanovski K, Koloska V, Polenakovic M. Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients. Prilozi. 2006 Jul;27(1):133-44.Search in Google Scholar

16. Silveberg D. Cardio-renal anemia iron deficiency syndrome (CRAID). Proceeding of 3^rd Cardionephrology Congress 2017;116-120Search in Google Scholar

17. Patel SI, Chakkera HA, Wennberg PW, Liedl DA, Alrabadi F, Cha SS, Hooley DD, Amer H, Wadei HM, Shamoun FE. Peripheral arterial disease preoperatively may predict graft failure and mortality in kidneytransplant recipients. Vasc Med. 2017;22(3):225-230.10.1177/1358863X1668983028466760Open DOISearch in Google Scholar

18. Rajagopalan S, Dellegrottaglie S, Furniss AL,. Peripheral arterial disease in patients with end-stage renal disease: Observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 2006; 114: 1914–192210.1161/CIRCULATIONAHA.105.60739017060384Search in Google Scholar

19. Gelev S, Spasovski G, BosevskiM, Tosev S, Sikole A. Different Ankle Brachial Index Levels in Asymptomatic Hemodialysis Patients. Bantao J 2006;4(2):41-6Search in Google Scholar

20. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis. 2005;45(4)(suppl 3):S1-S153.10.1053/j.ajkd.2005.01.019Search in Google Scholar

21. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(Suppl 1):S1-S75.10.1016/j.ejvs.2006.09.02417140820Search in Google Scholar

22. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463-e654.10.1161/CIRCULATIONAHA.106.173994Search in Google Scholar

23. Bosevski M, Soedamah-Muthu SS. Blood urea level and diabetes duration are independently associated with ankle-brachial index in type 2 diabetic patients. Diabetes Metab Syndr. 2012;6(1):32-5.10.1016/j.dsx.2012.05.00623014252Search in Google Scholar